Digestive Disease & Surgery Institute Outcomes
General Surgery ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall general surgery ACS NSQIP performance benchmarked against 701 participating sites.
|General Surgery (701 Sites)||N||Observed||Expected|
|30 Day Mortality||1287||1.48%||2.00%|
|30 Day Morbidity||1287||16.16%||17.03%|
|Ventilator > 48 Hours||1281||1.95%||1.75%|
|Deep Vein Thrombosis (DVT) / Pulmonary Embolus||1287||2.87%||2.39%|
|Urinary Tract Infection (UTI)||1287||1.01%||1.66%|
|Surgical Site Infection (SSI)||1277||8.93%||9.59%|
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.